Effectiveness Bank Analysis: French Committee Says Risks of Baclofen Outweigh Benefits in Alcohol Treatment
Submitted by Mike Ashton
- 26 April 2018
*Updated* Our commentary on the first trial to rigorously test high-dose baclofen to treat dependent drinking has been updated with the release on 24 April 2018 of an opinion on the balance between safety and benefits from a scientific committee set up by France’s medicines regulator to help decide on an application to market the drug.
